WHO ICTRP trial
Electrochemotherapy of liver metastatic lesions
IRCT20220103053611N1 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20220103053611N1 |
|---|---|
| Public title | Electrochemotherapy of liver metastatic lesions |
| Scientific title | Investigation of safety and size reduction of liver metastases from gastrointestinal cancers by electrochemotherapy in Imam Khomeini Hospital |
| Primary sponsor | Tehran University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 2 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Liver metastasis. Secondary malignant neoplasm of liver and intrahepatic bile duct;C78.7 |
| Interventions | Intervention group: Patients with gastrointestinal cancers who have liver metastases and need local treatment, but surgery and radiotherapy are not possible for them, are included in the study. For these patients under fluoroscope, needles… |
| Registration date | Jul 21, 2024 |
| Target size | 35 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: